Thrive: Building successful companies in the Madison Wisconsin USA region

Three Madison Wisconsin biotech/biomedical businesses discuss what makes their business successful in the Madison Region–from a startup (FluGen), a business just about to enter clinical trials (Quintessence) and a global headquarters with an IPO (TomoTherapy).

Executive One-on-One’s: Biotechnology Company Valuations & Exit Strategies–Video Leadership Seminar With James Sherblom of SeaFlower Ventures

Product Description
Executive One-on-One’s: Biotechnology Company Valuations & Exit Strategies – Video Leadership Seminar With James Sherblom of SeaFlower Ventures

The goal of this Video Leadership SeminarTM is to provide you with critical information on biotechnology company valuations and exit strategies. The DVD is viewable on any computer and features 60 minutes of live video with James Sherblom sharing his best practices on biotechnology venture capital, negotiation strategies and structuring deals.

Upon completion of the video, you will have a solid grasp of the most important points to understand in negotiating valuations and exit strategies. Topics covered in the video include:

Venture capital investment strategies in biotechnology companies
What VCs look for in determining valuations
Valuation calculations and multiples
Biggest external factors in establishing a valuation
How different venture capital firms differ in their valuation strategy
Valuation negotiation strategies and areas for negotiation
Biggest mistakes management teams make when negotiating valuations
How VCs value a start up company, profitable company, 10 year old company and other scenarios
Various exit strategies for biotechnology companies
IPO strategies
M&A strategies
Timing for exit strategies
Exit strategy negotiations
Raising current and future rounds of capital
Top 5 things for a management team to increase valuation

Executive One-on-One’s: Biotechnology Company Valuations & Exit Strategies–Video Leadership Seminar With James Sherblom of SeaFlower Ventures

Seattle’s Best logo makeover not so hot

Seattle’s Best logo makeover not so hot
Many commentators reacted to the new look of Seattle’s Best Coffee as though they’d been splashed in the eye with hot espresso. Also: A biotech company born in Seattle plans a big IPO.

Read more on Seattle Times

Biotech Investing: Every Investor’s Guide

Product Description
From the editor of the most influential biotech newsletter comes the most comprehensive investment guide on biotechnology.

Biotechnology is indisputably one of the fastest-growing and most promising industries. Virtually immune to swings in the economic cycles, biotech stocks continue to perform steadily as high-tech stocks lose their steam.

In Biotech Investing, Jim McCamant offers proven strategies and savvy advice on how to capitalize on the unprecedented opportunities in this high-potential sector. Written by a recognized authority, this book dissects biotech business models from start-up to IPO and discusses in detail the most important factors that affect biotech research. Comprehensive in scope, it looks at the best and worst biotech contenders, discusses all the most newsworthy developments in the field, and shows how they translate into business success or failure. It outlines simple criteria for choosing the best biotech stocks and for understanding the sometimes complicated dynamics of this sector.

Biotech Investing: Every Investor’s Guide